These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 2521266)

  • 1. The myocardium in congestive heart failure.
    Katz AM
    Am J Cardiol; 1989 Jan; 63(2):12A-16A. PubMed ID: 2521266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Energy requirements of contraction and relaxation: implications for inotropic stimulation of the failing heart.
    Katz AM
    Basic Res Cardiol; 1989; 84 Suppl 1():47-53. PubMed ID: 2530976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are inotropic agents contraindicated in congestive heart failure?
    Katz AM
    Cardiovasc Drugs Ther; 1989 Jan; 2(6):747-50. PubMed ID: 2488087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular mechanisms in congestive heart failure.
    Katz AM
    Am J Cardiol; 1988 Jul; 62(2):3A-8A. PubMed ID: 3291592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subcellular remodelling may induce cardiac dysfunction in congestive heart failure.
    Dhalla NS; Saini-Chohan HK; Rodriguez-Leyva D; Elimban V; Dent MR; Tappia PS
    Cardiovasc Res; 2009 Feb; 81(3):429-38. PubMed ID: 18852252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The heart in congestive failure.
    Katz AM
    Cardioscience; 1990 Mar; 1(1):3-6. PubMed ID: 2151711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subcellular remodeling as a viable target for the treatment of congestive heart failure.
    Dhalla NS; Dent MR; Tappia PS; Sethi R; Barta J; Goyal RK
    J Cardiovasc Pharmacol Ther; 2006 Mar; 11(1):31-45. PubMed ID: 16703218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of subcellular remodeling in cardiac dysfunction due to congestive heart failure.
    Babick AP; Dhalla NS
    Med Princ Pract; 2007; 16(2):81-9. PubMed ID: 17303941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms and abnormalities of contractility and relaxation in the failing heart.
    Katz AM
    Cardiologia; 1993 Dec; 38(12 Suppl 1):39-43. PubMed ID: 8020041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Congestive heart failure and expression of myocardial urotensin II.
    Douglas SA; Tayara L; Ohlstein EH; Halawa N; Giaid A
    Lancet; 2002 Jun; 359(9322):1990-7. PubMed ID: 12076554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial energetics in cardiac hypertrophy.
    Zhang J
    Clin Exp Pharmacol Physiol; 2002 Apr; 29(4):351-9. PubMed ID: 11985549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenergic neurohumors in the heart of hamsters with hereditary myopathy during cardiac hypertrophy and failure.
    Angelakos ET; Carballo LC; Daniels JB; King MP; Bajusz E
    Recent Adv Stud Cardiac Struct Metab; 1972; 1():262-78. PubMed ID: 4283440
    [No Abstract]   [Full Text] [Related]  

  • 13. [Myocardial metabolism in failing and hypertrophied hearts].
    Yazaki Y
    Kokyu To Junkan; 1987 Mar; 35(3):243-50. PubMed ID: 2954195
    [No Abstract]   [Full Text] [Related]  

  • 14. Induction of heart failure by minimally invasive aortic constriction in mice: reduced peroxisome proliferator-activated receptor γ coactivator levels and mitochondrial dysfunction.
    Faerber G; Barreto-Perreia F; Schoepe M; Gilsbach R; Schrepper A; Schwarzer M; Mohr FW; Hein L; Doenst T
    J Thorac Cardiovasc Surg; 2011 Feb; 141(2):492-500, 500.e1. PubMed ID: 20447656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic remodeling in hypertrophied and failing myocardium: a review.
    Peterzan MA; Lygate CA; Neubauer S; Rider OJ
    Am J Physiol Heart Circ Physiol; 2017 Sep; 313(3):H597-H616. PubMed ID: 28646030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autophagy during cardiac remodeling.
    Nishida K; Otsu K
    J Mol Cell Cardiol; 2016 Jun; 95():11-8. PubMed ID: 26678624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal intracellular calcium handling, a major cause of systolic and diastolic dysfunction in ventricular myocardium from patients with heart failure.
    Morgan JP; Erny RE; Allen PD; Grossman W; Gwathmey JK
    Circulation; 1990 Feb; 81(2 Suppl):III21-32. PubMed ID: 2153479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial phenotype changes in heart failure: cellular and subcellular adaptations and their functional significance.
    Hasenfuss G; Just H
    Br Heart J; 1994 Aug; 72(2 Suppl):S10-7. PubMed ID: 7946750
    [No Abstract]   [Full Text] [Related]  

  • 19. Metabolism of the failing heart.
    Katz AM
    Cardioscience; 1993 Dec; 4(4):199-203. PubMed ID: 8298061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic abnormalities in the diabetic heart.
    Lopaschuk GD
    Heart Fail Rev; 2002 Apr; 7(2):149-59. PubMed ID: 11988639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.